Analystreport

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.

SpringWorks Therapeutics, Inc. - common stock  (SWTX) 
Last springworks therapeutics, inc. - common stock earnings: 3/12 04:30 pm Check Earnings Report